Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA5281916
Max Phase: Preclinical
Molecular Formula: C15H12ClN3O4S
Molecular Weight: 365.80
Associated Items:
ID: ALA5281916
Max Phase: Preclinical
Molecular Formula: C15H12ClN3O4S
Molecular Weight: 365.80
Associated Items:
Canonical SMILES: COC(=O)C1=C(N)Oc2[nH]c(=S)[nH]c(=O)c2C1c1ccc(Cl)cc1
Standard InChI: InChI=1S/C15H12ClN3O4S/c1-22-14(21)9-8(6-2-4-7(16)5-3-6)10-12(20)18-15(24)19-13(10)23-11(9)17/h2-5,8H,17H2,1H3,(H2,18,19,20,24)
Standard InChI Key: BXOVFFCPJWDSOF-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 365.80 | Molecular Weight (Monoisotopic): 365.0237 | AlogP: 1.95 | #Rotatable Bonds: 2 |
Polar Surface Area: 110.20 | Molecular Species: NEUTRAL | HBA: 6 | HBD: 3 |
#RO5 Violations: 0 | HBA (Lipinski): 7 | HBD (Lipinski): 4 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: 7.80 | CX Basic pKa: | CX LogP: 2.14 | CX LogD: 2.00 |
Aromatic Rings: 2 | Heavy Atoms: 24 | QED Weighted: 0.55 | Np Likeness Score: -0.99 |
1. Elattar KM, El-Khateeb AY, Hamed SE.. (2022) Insights into the recent progress in the medicinal chemistry of pyranopyrimidine analogs., 13 (5.0): [PMID:35694689] [10.1039/d2md00076h] |
Source(1):